WallStSmart
WGRX

Wellgistics Health, Inc. Common Stock

NASDAQ: WGRX · HEALTHCARE · PHARMACEUTICAL RETAILERS

$0.08
+1.40% today

Updated 2026-06-05

Market cap
$9.35M
P/E ratio
P/S ratio
0.67x
EPS (TTM)
$-44.00
Dividend yield
52W range
$3 – $98
Volume
34.7M

Wellgistics Health, Inc. Common Stock (WGRX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 6
Last 6 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
-85.6%
Most recent quarter
EPS YoY growth
-423.0%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-11.8%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-25.9%
2026-05-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-05-19$-3.24$8.70$6.45-25.9%
2026-03-20$-13.75$6.00$6.30+5.1%
2025-11-19$-0.46$0.57$0.49-14.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-3.24$1.56M-85.6%
2025-12-31$-13.75$1.67M-110.4%
2025-09-30$-0.46$3.01M
2025-06-30$-0.11$7.79M
2025-03-31$-0.62$10.86M
2024-12-31$0.00$-0.09$-16.05M

Frequently asked questions

Has Wellgistics Health, Inc. Common Stock beaten earnings estimates?

Wellgistics Health, Inc. Common Stock has beaten Wall Street EPS estimates in 0 of its last 6 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does WGRX stock react to earnings?

WGRX has moved an average of -11.8% the day after earnings over its last 3 reports, finishing higher after 1 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.

What is Wellgistics Health, Inc. Common Stock's revenue growth rate?

Wellgistics Health, Inc. Common Stock reported year-over-year revenue growth of -85.6% in its most recent quarter, with EPS up -423.0%. Reading revenue growth alongside margins shows whether that growth is translating into profit.